Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 7 min ago

Oncology

5,176 studies502 in 7 days2,477 in 30 days

Filters
Type
Date
Clear

Latest

5,176 studies

  1. 978 Investigating the mechanisms underlying TRM dysfunction in ICI-induced colitis
    Martina Damo, Emily Schahrer, Paul Chak Mou Ngai +4
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  2. 944 Succinate-based metabolic reprogramming of innate and adaptive immunity for ovarian cancer immunotherapy
    Remya Raja, Christopher Wu, Marion Curtis +6
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  3. 535 BC3195, a novel cadherin-3 targeting antibody drug conjugate, combined with pembrolizumab in patients with advanced solid malignancies: preliminary results from a phase I/II study (BC3195-103/G36)
    Yi-Long Wu, Hai-jun Guo, Chongrui Xu +5
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. 974 Integrated multimodal profiling reveals conserved type II interferon signalling, ectopic lymphoid structure formation, and actionable inflammatory endotypes in cutaneous immune-related adverse events
    James Larkin, Samra Turajlic, Teena Thakur +10
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  5. 483 Intralesional PD-1 blockade induces localized immune mobilization and coordinated lymphatic niche assembly in high-risk oral premalignant lesions
    Padmanee Sharma, Sonali Jindal, Sreyashi Basu +32
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  6. 36 Baseline systemic immune profiles predict prognosis and differential benefit from ipilimumab intensification in relapsed mesothelioma (Bio-IFCT-1501 MAPS2 trial)
    Julien Mazières, Aurélien Marabelle, Arnaud Scherpereel +12
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  7. 1161 Novel IL1RAP expression gradient modulates the myeloid cell phenotype and T-cell infiltration patterns of the Ewing sarcoma immune microenvironment
    Robert Anders, Carol Morris, Adam Levin +9
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  8. Novel Copper (II) Complex Derived from Sulfadiazine Azo Resorcinol Ligand: Characterization, Antibacterial Evaluation, and Molecular Docking Study.
    Hawraa Ibrahim, Abeer Tuaimah, Zahraa Salman
    Biobacta Journal of Biochemistry and Molecular BiologyPeer-reviewedCC BY-SAFull textOncologyDOAJ
  9. Dynamic mutator states in cancer
    Moawiah M. Naffaa
    Frontiers in GeneticsPeer-reviewedCC BYFull textOncologyDOAJ
  10. 2 Preclinical modeling of human glioblastoma immunotherapy resistance using a STING pathway defective mouse model
    Apoorvi Chaudhri, Ping Hua, Gordon J Freeman +4
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  11. Biliary Drainage and Complex Hepatobiliary Surgery in Biliary Tract Cancers: A Framework for Selective Centralization
    Dennis Björk, Emine Selda Gündüz, Piotr Kalinowski +6
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  12. Senescence-Related Transcriptomic Analysis and Functional Characterization of ANGPTL4 in Lung Adenocarcinoma
    Ying Shi, Han Zhang, Yuhang Jiang +2
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  13. Vitamin D Receptor Genotype, Tumor Expression, and Outcomes After Vitamin D Supplementation in Digestive Tract Cancer: An Exploratory Post Hoc Analysis of the AMATERASU Trial
    Tadashi Matsushima, Akitaka Sasaki, Taisuke Akutsu +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  14. The WNT Inhibitor PRI-724 Depletes Endogenous SOX2 and Blocks SOX2 Upregulation by Therapeutic Regimes
    Alexander R. Sage, Daisy V. Gonzalez, Briana D. Ormsbee Golden +7
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  15. Preoperative Risk Classification for Early Recurrence After Curative-Intent Resection of Perihilar Cholangiocarcinoma: A Single-Center Retrospective Study
    Yu Fujimura, Naohisa Kuriyama, Yuki Segi +10
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  16. Explainable DSC Perfusion Radiomics for Post-Treatment Glioblastoma Assessment Using a Soft-Voting Machine-Learning Ensemble
    Rafail C. Christodoulou, Giorgos Christofi, Georgios Vamvouras +6
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  17. Revealing the Invisible: Circulating and Urinary Tumor DNA in Bladder Cancer
    Sophia L. Qin, Benista Owusu-Amo, David T. Miyamoto
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  18. Lower Dexamethasone Dose in Multiple Myeloma: A Multicenter Retrospective Analysis
    Lili Korpás, Ádám Wiedemann, Fruzsina Szél +21
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  19. Antibody–Drug Conjugates Plus Immune Checkpoint Inhibitors for Sustained Disease Control in Advanced Solid Tumors
    Meiling Xu, Jun Yin, Yao Li +1
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  20. Longitudinal Changes in Visual Field and Optical Coherence Tomography Parameters in Patients with Pituitary Microadenomas: A 12-Month Controlled Study
    Monika Sarnat-Kucharczyk, Małgorzata A. Janik, Paweł Janik +2
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  21. Circulating Neurotransmitters, Neuropeptides, and Neuroactive Mediators in Gastric Cancer: A Systematic Review of Diagnostic, Prognostic, and Clinicopathological Evidence
    Bogdan Cristian Albu, Ancuța-Ramona Camen, Mihail Virgil Boldeanu +8
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  22. Health Disparities in Management of Keratinocyte Carcinoma: A Multicenter Observational Study
    Margaux Debaveye, Laura Destrooper, Rick Waalboer-Spuij +2
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  23. A single-cell transcriptomics-based prognostic model identifies TM4SF1 as a key promoter of malignant progression in lung adenocarcinoma
    Jiahua Li, Tianci Liu, Ling Li +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  24. A reserpine-induced spleen-deficiency-like state is associated with aggravated cancer cachexia and metabolic-marker alterations following Liu-Jun-Zi Decoction treatment in mice
    Shilong Zhu, Yazhou Sang, Yijun Wang +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyFrontiersCrossrefDOAJ
  25. Impact of consolidative HSCT after CAR T-cell–induced remission in pediatric relapsed/refractory B-ALL: a single-center retrospective cohort
    Ziwei Liao, Feimei Kuang, Yuxuan Luo +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref